N-of-One builds precision medicine oncology decision support solutions that analyze each patient’s unique molecular profile and integrate multiple molecular tests with a proprietary knowledgebase. Its team of oncologists and Ph.D. scientists works with leading hospital systems and commercial labs to standardize and accelerate genomic clinical interpretation and molecular decision support. N-of-One’s solutions have identified treatment options, including molecularly matched clinical trials, for tens of thousands of cancer patients across hundreds of cancer types. The company announced a $7 million Series B financing from Providence Ventures and Excel Venture Management. N-of-One plans to use the financing to expand R&D to broaden its clinical decision support offerings, incorporate clinical data alongside molecular profiles to refine treatment recommendations, and expand sales and marketing in the U.S. and strategic global markets. It partners with leading healthcare systems and large commercial labs to scale molecular oncology decision making and bring precision medicine to more patients.

Total raised

$7M

Funding rounds

1

Latest round

Series B

Latest activity

Jul 2016